VolcaNO Extreme Tablets
VolcaNO Extreme Tablets, licence 80088895: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Force Factor Brands LLC
- NPN or DIN-HM
- 80088895
- Status
- Active licence
- Licence date
- 24 October 2018
- Revision date
- 18 October 2021
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Glycine, N-(aminoiminométhyl)-N-méthyl-, monohydrochlorure Source : Chlorhydrate de créatine | 250.0 mg | Not calculated |
| L-Citrulline Source : Citrulline | 250.0 mg | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 1250 mg Potency : 95.0 % Polyphenols | 50.0 mg | Not calculated |
| L-alpha-Glycérophosphorylcholine Source : Alfoscérate de choline | 33.33 mg | Not calculated |
| Huperzia serrata Source : Plante entière Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 83.5 mg Potency : 1.0 % Huperzine A | 1.67 mg | Not calculated |
| L-arginine Source : Arginine silicate inositol | 225.0 mg | Not calculated |
| L-arginine Source : Arginine silicate inositol | 500.0 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de titane, Silice, Jaune FD&C n° 6, Phosphate de calcium, dibasique, Hydroxypropyl méthylcellulose, Rouge D&C no. 27, Propylène glycol, Croscarmellose de sodium, Stéarate de magnésium, Triacétine, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 3.0 Comprimé | 1.0 Tous les jours |
| Adultes | Not specified | 3.0 Comprimé | minimum: 2.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Workout supplement. Athletic support. L-Arginine is a non-essential amino acid that is involved in protein synthesis. Source of antioxidants for the maintenance of good health. Increases [fat-free/body/muscle/lean] [mass/size] when used in conjunction with a resistance training regimen. Improves [strength/power/performance] in repetitive bouts of brief, highly-intense physical activity (e.g. sprints, jumping, resistance training) by increasing [muscle/intramuscular] [creatine/phosphocreatine/energy] levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience gastrointestinal discomfort (such as diarrhea). May result in weight gain.
- Contre-indications
Do not use if you have had a heart attack/myocardial infarction.
- Précautions et mises en garde
Ensure to drink enough fluid before, during, and after exercise. If you are pregnant or breastfeeding, consult a healthcare practitioner before using this product. Consult a health care practitioner if your cardiovascular condition worsens. Consult a health care practitioner prior to use if you have a renal/kidney disease or if you are following a low protein diet. Consult a health care practitioner prior to use if you suffer from a cardiovascular disease and are attempting an increase in physical activity. Consult your health care practitioner prior to use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners. If you have high blood pressure or a seizure disorder, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80088895
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.